Underwriting the deal is Morgan Stanley, BofA Securities, and CICC. Law360 (April 11, 2022, 4:58 PM EDT) - LinkDoc Technology Ltd.
The company expects to float its American depositary shares on the Nasdaq Global Select Market under the symbol "LDOC." LinkDoc set $100 million as its IPO target the exact terms of the deal are yet to be announced. Another backer in LinkDoc is an affiliate of Singapore's Temasek Holdings. (HKEX: 0241), which held 8.4% in the company as of the date of the prospectus. LinkDoc counts among its investors Alibaba Health Information Technology Ltd. He had also founded Truststone, which provided pharmaceutical and medical institutions with hospital infosystems. The seven-year-old platform is led by Tianze Zhang, who previously worked at Chinese tech conglomerates Tencent (HKEX: 0700 OTC: TCEHY) and Alibaba. The company said it intends to use the proceeds from the IPO to boost R&D, bring more oncologists, data scientists and other experienced professionals onboard, expand its patient care center network and service offerings, and pursue potential strategic investments and acquisitions. In the three months through March 2021, LinkDoc had $34.1 million in revenues on losses of $20.7 million. Institute For Research (Tiaer), Support For Total Maximum Daily Loads for Indicator Bacteria Listing in North Fork. Net loss widened 12% to $72.6 million, according to the filing.
In 2020, LinkDoc booked $143.7 million in revenues, up 89% year-over-year. HONG KONG (July 8): Chinese medical data group LinkDoc Technology Ltd has shelved plans for an IPO in the United States following Beijing's clampdown on overseas listings by domestic firms, according to three sources with direct knowledge of the matter.It is the first known Chinese firm to pull back from its IPO plans since the crackdown began last week with an investigation by China's. As it said in the prospectus, filed Monday, this consists of "LinkCare, a digital continuous care platform for patients with critical diseases, LinkData, an AI-enabled curation system for longitudinal medical data, and LinkSolutions, a data-driven precision life sciences solution platform that helps life sciences companies accelerate clinical research and real-world evidence adoption." According to Frost & Sullivan, the company operates China's largest data-driven digital infrastructure for precision medicine. LinkDoc Technology Ltd., backed by the health unit of Alibaba Group (NYSE: BABA HKEX: 9988), has filed for an initial public offering in New York.īased in Beijing, LinkDoc is a healthcare technology company focusing on oncology.
0 kommentar(er)
